{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Calculated from the date of AUTO2 treatment to the date of progression or death. Patients who have not progressed or relapsed was censored at the last adequate disease assessment","groups":[{"description":"Relapsed or refractory myeloma patients.","id":"OG000","title":"AUTO2"}],"populationDescription":"Analysis was not performed due to not enough patients who had a response (VGPR, PR) to justify the progression-free survival. The study was terminated early and Phase 2 was not started.","reportingStatus":"POSTED","timeFrame":"Up to 2 years","title":"Progression-free Survival","type":"SECONDARY"}